15-C Treatment of cancers by magnetic guidance of bacteria loaded with therapeutic agents.

15-C Treatment of cancers by magnetic guidance of bacteria loaded with therapeutic agents. Summary The Starpax treatment is a revolutionary technology unlike any other on the planet. Itallows the drug to be transported directly to the tumor without passing through the bloodstream, leaving untargeted organs intact. Starpax Medical inc. has developed a unique system for the…

14-D DREAMLAND; MOBILE Project

14-D DREAMLAND; MOBILE Project Summary CONTEXT: Each year, more than 40 severely burned children aged 6 to 17 are treated at the CHU Sainte-Justine trauma center. The treatment of burns, dressing changes as well as physiotherapy and occupational therapy are considered to be among the most painful medical procedures. These are usually recurrent treatments that generate a lot of…

12-I Dosimetric and radiobiologic characterization and development of a novel technology for intratumoral radiotherapy with alpha particles (DaRT) using microfluidic Lab‐on‐a‐chip technology

12-I Dosimetric and radiobiologic characterization and development of a novel technology for intratumoral radiotherapy with alpha particles (DaRT) using microfluidic Lab‐on‐a‐chip technology Summary Each year, 80 000 Canadiens will die from cancer which is the main cause of death in Canada despite continuous effort to improve established treatment technologies such as…

12-H Development of new pharmacological agents for optimization of stem cells and organs to enhance the clinical outcome of regenerative medicine and transplantation procedures

12-H Development of new pharmacological agents for optimization of stem cells and organs to enhance the clinical outcome of regenerative medicine and transplantation procedures Summary The project involves development and testing of novel molecules that are used to improve cell and organ function for the clinical optimization of regenerative medicine and transplantation outcomes.…

12-F Development of new pharmacological agents for optimization of stem cells and organs to enhance the clinical outcome of regenerative medicine and transplantation procedures

12-F Development of new pharmacological agents for optimization of stem cells and organs to enhance the clinical outcome of regenerative medicine and transplantation procedures Summary The project involves development and testing of novel molecules that are used to improve cell and organ function for the clinical optimization of regenerative medicine and transplantation outcomes. Two…

13-CA Delivering Evidence Based Care using artificial Intelligence to Patients with Diabetes and CardioVascular Comorbidities: The DECIDE-CV Innovation Project

13-CA Delivering Evidence Based Care using artificial Intelligence to Patients with Diabetes and CardioVascular Comorbidities: The DECIDE-CV Innovation Project Summary The epidemic of type 2 diabetes mellitus (T2DM) has afflicted more than in 1 in 10 Canadian. T2DM is associated with an increased risk of heart attacks, heart failure, stroke, blindness, kidney failure, and lower-limb…

Demonstration and validation of a chest patch capable of monitor children’s vital signs in real time using Artificial Intelligence

Demonstration and validation of a chest patch capable of monitor children’s vital signs in real time using Artificial Intelligence Summary The readmission of patients to pediatric intensive care units (PICU) after discharge, although a rare event, is a matter of major concern for intensive care physicians because it is associated with a sharp increase in morbidity and mortality. The…